Guideline: Evidence-Based Best Practices for the Management of Cancer-Related Pain
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
All articles by Lauren Biscaldi
Heparin to Dabigatran Switch Safe, Effective in Patients With Intermediate-Risk Pulmonary Embolism
Researchers assessed whether treatment of acute intermediate-risk pulmonary embolism with parenteral anticoagulation followed by a switch to a direct oral anticoagulant was effective and safe.
CMR Imaging to Detect Myocarditis in Athletes After Recent SARS-CoV-2 Infection
The prevalence of myocarditis in athletes following symptomatic or asymptomatic COVID-19 infection and compare screening strategies for safe return to play.
AHA/ACC Consensus Statement on Medical Professionalism and Ethics
The American Heart Association and the American College of Cardiology believe there is “no better time to review and take a fresh perspective on medical ethics and professionalism in the light of established norms and current stressors.”
Single-Inhaler Triple Therapy Reduces Composite AE Risk vs Dual Therapy in COPD
Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations.
Gefapixant Associated With Clinically Meaningful Reduction in Chronic Cough Frequency
Twice daily gefapixant 45 mg was associated with a clinically meaningful reduction in cough frequency in patients with chronic cough.
Early Initiation of Tocilizumab May Preserve Lung Function in SSc-ILD
Early identification if interstitial lung disease (ILD), followed by subsequent tocilizumab therapy initiation, may preserve lung function in patients with systemic sclerosis-associated ILD.
Proof-of-Concept Biomarker-Based Scale Can Predict Asthma Attacks
The novel ORACLE scale (Oxford Asthma Attack Risk Scale) demonstrated potential to predict — and subsequently prevent — asthma attacks using biomarkers of type 2 airway inflammation.
Oral Corticosteroid Dose Management With Impaired Adrenal Function Evaluated
Patients with normal adrenal function are largely able to eliminate the use of oral corticosteroids or achieve a daily dose of 5 mg or less.
Dual Bronchodilation vs Triple Therapy Evaluated for Mortality Rates in COPD
Both dual bronchodilation and triple therapy demonstrated similar rates of mortality in patients with moderate to severe COPD at low risk for exacerbations.
- Loading...
Loading...
Next post in ATS 2021
Loading... 
Loading...